Bone Biologics Corporation (BBLG) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $2.4M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Led by Jeffrey Frelick, public since 2021-10-13.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for BBLG as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →